Two rats, one black and one white, are sitting on food on a black surface against a black background, with the black rat eating a piece of bread.

In Vivo Services

In Vivo services are essential in the drug development process, ensuring new therapies are thoroughly evaluated for effectiveness and safety before clinical trials.

By assessing factors like efficacy, toxicity, and pharmacokinetic/pharmacodynamic (PK/PD) profiles, sponsors can make informed decisions about their drug candidates. This rigorous evaluation increases the chances of success in later stages and facilitates regulatory approvals. Ultimately, these services help mitigate risks, optimize trial design, and support the development of innovative therapies that can significantly enhance patient outcomes

A computer monitor displaying a graph with concentration on the y-axis and time on the x-axis, showing a decreasing curve.

Trust Our Pre-clinical Expertise

PK/PD

We are dedicated to providing expertise in PK/PD modeling and simulation across a variety of techniques and applications, assisting clients in determining optimal dosage levels for efficacy studies. By blending scientific rigor with creative insight, we help clients select precise models that reveal the pharmacokinetic characteristics of compounds in early clinical trials.

A pink pill bottle with a skull and crossbones symbol and a capsule pill next to it, indicating dangerous or toxic medication.

Toxicology/Safety

Our preclinical research team, comprising board-certified toxicologists, regulatory specialists, and support staff, has over 20 years of experience in designing and conducting safety assessment programs. We utilize a wide variety of animal models and administration routes to evaluate acute and chronic toxicity, as well as carcinogenicity.

Efficacy

Efficacy services provide critical data that inform regulatory submissions and support the design of clinical trials. By establishing a clear understanding of a drug's efficacy early in the development process, we help sponsors with making informed decisions, reducing the risk of late-stage failures, and enhancing the chances of successful regulatory approval.